|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S1
|
$35,000
|
$1,050
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
3P30CA016359-33S2
|
$5,000
|
$150
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-33
|
$1,795,225
|
$53,857
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Vitamin D Analogs as Adjuvants in Chemotherapy
|
5R01CA044722-21
|
$199,759
|
$99,880
|
Studzinski, GEORGE
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
|
Virus-Targeted Therapy for Malignancies
|
1R43CA153474-01A1
|
$288,895
|
$288,895
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
Validation of microRNAs as therapeutic targets in hematological malignancies
|
1R01CA135332-01A2
|
$316,438
|
$158,219
|
MARCUCCI, GUIDO
|
OHIO STATE UNIVERSITY
|
|
Validating a novel biomarker of clinical progression and survival in CLL
|
1R33CA161731-01
|
$364,620
|
$364,620
|
DAVIS, RANDALL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S1
|
$74,970
|
$750
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-38S2
|
$139,926
|
$1,399
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-38
|
$4,555,705
|
$45,557
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UT M.D. Anderson Cancer Center
|
5U10CA045809-23
|
$2,179,856
|
$108,993
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
2P30CA014089-36
|
$6,160,984
|
$61,610
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S1
|
$50,000
|
$500
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S2
|
$244,500
|
$2,445
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
3P30CA014089-36S3
|
$74,923
|
$749
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
University of Texas M.D. Anderson Cancer Center SPORE - Leukemia
|
5P50CA100632-09
|
$2,185,000
|
$1,114,350
|
Kantarjian, Hagop
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S2
|
$50,000
|
$500
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-23S3
|
$5,694,947
|
$56,949
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Understanding Hemotopoietic Neoplasias using Humanized Mice
|
5R01CA156689-02
|
$507,346
|
$507,346
|
FLAVELL, RICHARD
|
YALE UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-12S1
|
$75,000
|
$750
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-12
|
$2,947,311
|
$29,473
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Investigation of KRas & NF1 in Myeloid Leukemia
|
5R37CA072614-15
|
$300,946
|
$300,946
|
SHANNON, KEVIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
Transcription Factor Regulation by the BCR/ABL Oncogene
|
4R01CA095111-08
|
$301,843
|
$150,922
|
CALABRETTA, BRUNO
|
THOMAS JEFFERSON UNIVERSITY
|
|
TOWARD AN UNDERSTANDING OF CLL PROGRESSION
|
1R01CA151319-01A1
|
$375,231
|
$375,231
|
CROCE, CARLO
|
OHIO STATE UNIVERSITY
|
|
The Therapy of CML
|
5P01CA049639-21
|
$3,438,273
|
$3,438,273
|
CHAMPLIN, RICHARD
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
The Role of the APC Tumor Suppressor Gene in Hematopoiesis and Leukemogenesis
|
7R01CA140979-02
|
$293,198
|
$293,198
|
QIAN, ZHIJIAN
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
The Role of Oncogenic Ras in Leukemogenesis and Response to Targeted Therapies
|
5K08CA134649-04
|
$127,170
|
$63,585
|
Li, Qing
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
The role of Hedgehog in hematopoiesis and leukemogenesis
|
5K08CA140723-02
|
$168,588
|
$84,294
|
Hofmann Zhang, Inga
|
CHILDREN'S HOSPITAL BOSTON
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S1
|
$72,130
|
$4,328
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-18S2
|
$75,000
|
$4,500
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-18
|
$4,829,858
|
$289,791
|
Rosen, Steven
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Immunobiology of Marrow Allografts for Leukemia
|
5P01CA023766-33
|
$3,002,066
|
$600,413
|
O'REILLY, Richard
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
Targeting Wnt/Ca2+ Pathway components and Bcr-Abl for the treatment of CML
|
5K01CA133182-03
|
$115,170
|
$115,170
|
GREGORY, MARK
|
UNIVERSITY OF COLORADO DENVER
|
|
Targeting PML for therapy in leukemia-initiating cells
|
5K99CA139009-02
|
$89,144
|
$89,144
|
Ito, Keisuke
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting PML for leukemia therapy.
|
5R01CA142874-02
|
$457,498
|
$457,498
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting Leukemic Stem Cells
|
5R01CA138211-04
|
$419,335
|
$209,668
|
TENEN, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeted Improvement in Stem Cell Therapy for Leukemia and Bone Marrow Failure Sy
|
1R01CA157537-01
|
$317,042
|
$317,042
|
PANG, QISHEN
|
CHILDREN'S HOSPITAL MEDICAL CENTER CINCI
|
|
Systems Biology of Diversity in Cancer
|
5U54CA148967-02
|
$2,716,373
|
$298,801
|
SANDER, CHRIS
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
SunCoast CCOP Research Base at the University of South Florida
|
5U10CA081920-10
|
$1,497,393
|
$29,948
|
KRISCHER, JEFFREY
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Study of the Roles of SDF1 and CXCR4 in Hematopoiesis
|
ZIA BC 010782
|
$370,199
|
$92,549
|
Tosato, Giovanna
|
CCR (NCI)
|
|
Studies of Proteins with Important Roles in Immunology and/or Cancer Biology
|
ZIA BC 010761
|
$323,676
|
$129,470
|
Lubkowski, Jacek
|
CCR (NCI)
|
|
Stanford University Cancer Center
|
3P30CA124435-05S1
|
$74,525
|
$1,491
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
Stanford University Cancer Center
|
5P30CA124435-05
|
$3,091,618
|
$61,832
|
MITCHELL, BEVERLY
|
STANFORD UNIVERSITY
|
|
SPORE in Lymphoma
|
5P50CA126752-05
|
$2,153,287
|
$236,862
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S1
|
$112,399
|
$2,248
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S2
|
$250,000
|
$5,000
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S3
|
$250,000
|
$5,000
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S4
|
$50,000
|
$1,000
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
3P30CA023100-27S5
|
$75,000
|
$1,500
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Specialized Cancer Center Support Grant
|
5P30CA023100-27
|
$3,805,377
|
$76,108
|
KIPPS, THOMAS
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
Total relevant funding to Chronic Myeloproliferative Disorders for this search: $41,079,547
|